Skip to main content
Top
Published in: Molecular Cancer 1/2006

Open Access 01-12-2006 | Research

Tumor cell invasion of collagen matrices requires coordinate lipid agonist-induced G-protein and membrane-type matrix metalloproteinase-1-dependent signaling

Authors: Kevin E Fisher, Andreia Pop, Wonshill Koh, Nicholas J Anthis, W Brian Saunders, George E Davis

Published in: Molecular Cancer | Issue 1/2006

Login to get access

Abstract

Background

Lysophosphatidic acid (LPA) and sphingosine 1-phosphate (S1P) are bioactive lipid signaling molecules implicated in tumor dissemination. Membrane-type matrix metalloproteinase 1 (MT1-MMP) is a membrane-tethered collagenase thought to be involved in tumor invasion via extracellular matrix degradation. In this study, we investigated the molecular requirements for LPA- and S1P-regulated tumor cell migration in two dimensions (2D) and invasion of three-dimensional (3D) collagen matrices and, in particular, evaluated the role of MT1-MMP in this process.

Results

LPA stimulated while S1P inhibited migration of most tumor lines in Boyden chamber assays. Conversely, HT1080 fibrosarcoma cells migrated in response to both lipids. HT1080 cells also markedly invaded 3D collagen matrices (~700 μm over 48 hours) in response to either lipid. siRNA targeting of LPA1 and Rac1, or S1P1, Rac1, and Cdc42 specifically inhibited LPA- or S1P-induced HT1080 invasion, respectively. Analysis of LPA-induced HT1080 motility on 2D substrates vs. 3D matrices revealed that synthetic MMP inhibitors markedly reduced the distance (~125 μm vs. ~45 μm) and velocity of invasion (~0.09 μm/min vs. ~0.03 μm/min) only when cells navigated 3D matrices signifying a role for MMPs exclusively in invasion. Additionally, tissue inhibitors of metalloproteinases (TIMPs)-2, -3, and -4, but not TIMP-1, blocked lipid agonist-induced invasion indicating a role for membrane-type (MT)-MMPs. Furthermore, MT1-MMP expression in several tumor lines directly correlated with LPA-induced invasion. HEK293s, which neither express MT1-MMP nor invade in the presence of LPA, were transfected with MT1-MMP cDNA, and subsequently invaded in response to LPA. When HT1080 cells were seeded on top of or within collagen matrices, siRNA targeting of MT1-MMP, but not other MMPs, inhibited lipid agonist-induced invasion establishing a requisite role for MT1-MMP in this process.

Conclusion

LPA is a fundamental regulator of MT1-MMP-dependent tumor cell invasion of 3D collagen matrices. In contrast, S1P appears to act as an inhibitory stimulus in most cases, while stimulating only select tumor lines. MT1-MMP is required only when tumor cells navigate 3D barriers and not when cells migrate on 2D substrata. We demonstrate that tumor cells require coordinate regulation of LPA/S1P receptors and Rho GTPases to migrate, and additionally, require MT1-MMP in order to invade collagen matrices during neoplastic progression.
Appendix
Available only for authorised users
Literature
1.
go back to reference Stetler-Stevenson WG, Aznavoorian S, Liotta LA: Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu Rev Cell Biol. 1993, 9 (1): 541-573. 10.1146/annurev.cb.09.110193.002545CrossRefPubMed Stetler-Stevenson WG, Aznavoorian S, Liotta LA: Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu Rev Cell Biol. 1993, 9 (1): 541-573. 10.1146/annurev.cb.09.110193.002545CrossRefPubMed
2.
go back to reference Mignatti P, Rifkin DB: Biology and biochemistry of proteinases in tumor invasion. Physiol Rev. 1993, 73 (1): 161-195.PubMed Mignatti P, Rifkin DB: Biology and biochemistry of proteinases in tumor invasion. Physiol Rev. 1993, 73 (1): 161-195.PubMed
3.
go back to reference Friedl P, Wolf K: Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer. 2003, 3 (5): 362-374. 10.1038/nrc1075CrossRefPubMed Friedl P, Wolf K: Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer. 2003, 3 (5): 362-374. 10.1038/nrc1075CrossRefPubMed
4.
go back to reference Gehlsen KR, Davis GE, Sriramarao P: Integrin expression in human melanoma cells with differing invasive and metastatic properties. Clin Exp Metastasis. 1992, 10 (2): 111-120. 10.1007/BF00114587CrossRefPubMed Gehlsen KR, Davis GE, Sriramarao P: Integrin expression in human melanoma cells with differing invasive and metastatic properties. Clin Exp Metastasis. 1992, 10 (2): 111-120. 10.1007/BF00114587CrossRefPubMed
5.
go back to reference Sabeh F, Ota I, Holmbeck K, Birkedal-Hansen H, Soloway P, Balbin M, Lopez-Otin C, Shapiro S, Inada M, Krane S, Allen E, Chung D, Weiss SJ: Tumor cell traffic through the extracellular matrix is controlled by the membrane-anchored collagenase MT1-MMP. J Cell Biol. 2004, 167 (4): 769-781. 10.1083/jcb.200408028PubMedCentralCrossRefPubMed Sabeh F, Ota I, Holmbeck K, Birkedal-Hansen H, Soloway P, Balbin M, Lopez-Otin C, Shapiro S, Inada M, Krane S, Allen E, Chung D, Weiss SJ: Tumor cell traffic through the extracellular matrix is controlled by the membrane-anchored collagenase MT1-MMP. J Cell Biol. 2004, 167 (4): 769-781. 10.1083/jcb.200408028PubMedCentralCrossRefPubMed
6.
go back to reference Seiki M: Membrane-type 1 matrix metalloproteinase: a key enzyme for tumor invasion. Cancer Lett. 2003, 194 (1): 1-11. 10.1016/S0304-3835(02)00699-7CrossRefPubMed Seiki M: Membrane-type 1 matrix metalloproteinase: a key enzyme for tumor invasion. Cancer Lett. 2003, 194 (1): 1-11. 10.1016/S0304-3835(02)00699-7CrossRefPubMed
7.
go back to reference Chambers AF, Groom AC, MacDonald IC: Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer. 2002, 2 (8): 563-572. 10.1038/nrc865CrossRefPubMed Chambers AF, Groom AC, MacDonald IC: Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer. 2002, 2 (8): 563-572. 10.1038/nrc865CrossRefPubMed
8.
go back to reference Ridley AJ, Schwartz MA, Burridge K, Firtel RA, Ginsberg MH, Borisy G, Parsons JT, Horwitz AR: Cell migration: integrating signals from front to back. Science. 2003, 302 (5651): 1704-1709. 10.1126/science.1092053CrossRefPubMed Ridley AJ, Schwartz MA, Burridge K, Firtel RA, Ginsberg MH, Borisy G, Parsons JT, Horwitz AR: Cell migration: integrating signals from front to back. Science. 2003, 302 (5651): 1704-1709. 10.1126/science.1092053CrossRefPubMed
9.
go back to reference Hanahan D, Weinberg RA: The Hallmarks of Cancer. Cell. 2000, 100 (1): 57-70. 10.1016/S0092-8674(00)81683-9CrossRefPubMed Hanahan D, Weinberg RA: The Hallmarks of Cancer. Cell. 2000, 100 (1): 57-70. 10.1016/S0092-8674(00)81683-9CrossRefPubMed
10.
go back to reference Sporn MB: The war on cancer. The Lancet. 1996, 347 (9012): 1377-1381. 10.1016/S0140-6736(96)91015-6.CrossRef Sporn MB: The war on cancer. The Lancet. 1996, 347 (9012): 1377-1381. 10.1016/S0140-6736(96)91015-6.CrossRef
11.
go back to reference Hla T: Signaling and biological actions of sphingosine 1-phosphate. Pharmacol Res. 2003, 47 (5): 401-407. 10.1016/S1043-6618(03)00046-XCrossRefPubMed Hla T: Signaling and biological actions of sphingosine 1-phosphate. Pharmacol Res. 2003, 47 (5): 401-407. 10.1016/S1043-6618(03)00046-XCrossRefPubMed
12.
go back to reference Goetzl EJ, Wang W, McGiffert C, Huang MC, Graler MH: Sphingosine 1-phosphate and its G protein-coupled receptors constitute a multifunctional immunoregulatory system. J Cell Biochem. 2004, 92 (6): 1104-1114. 10.1002/jcb.20053PubMedCentralCrossRefPubMed Goetzl EJ, Wang W, McGiffert C, Huang MC, Graler MH: Sphingosine 1-phosphate and its G protein-coupled receptors constitute a multifunctional immunoregulatory system. J Cell Biochem. 2004, 92 (6): 1104-1114. 10.1002/jcb.20053PubMedCentralCrossRefPubMed
13.
go back to reference Lee H, Goetzl EJ, An S: Lysophosphatidic acid and sphingosine 1-phosphate stimulate endothelial cell wound healing. Am J Physiol Cell Physiol. 2000, 278 (3): C612-8.PubMed Lee H, Goetzl EJ, An S: Lysophosphatidic acid and sphingosine 1-phosphate stimulate endothelial cell wound healing. Am J Physiol Cell Physiol. 2000, 278 (3): C612-8.PubMed
14.
go back to reference Saba JD: Lysophospholipids in development: Miles apart and edging in. J Cell Biochem. 2004, 92 (5): 967-992. 10.1002/jcb.20128CrossRefPubMed Saba JD: Lysophospholipids in development: Miles apart and edging in. J Cell Biochem. 2004, 92 (5): 967-992. 10.1002/jcb.20128CrossRefPubMed
15.
go back to reference Panetti TS: Differential effects of sphingosine 1-phosphate and lysophosphatidic acid on endothelial cells. Biochim Biophys Acta. 2002, 1582 (1-3): 190-196.CrossRefPubMed Panetti TS: Differential effects of sphingosine 1-phosphate and lysophosphatidic acid on endothelial cells. Biochim Biophys Acta. 2002, 1582 (1-3): 190-196.CrossRefPubMed
16.
go back to reference Kluk MJ, Hla T: Signaling of sphingosine-1-phosphate via the S1P/EDG-family of G-protein-coupled receptors. Biochim Biophys Acta. 2002, 1582 (1-3): 72-80.CrossRefPubMed Kluk MJ, Hla T: Signaling of sphingosine-1-phosphate via the S1P/EDG-family of G-protein-coupled receptors. Biochim Biophys Acta. 2002, 1582 (1-3): 72-80.CrossRefPubMed
17.
go back to reference Whitehead IP, Zohn IE, Der CJ: Rho GTPase-dependent transformation by G protein-coupled receptors. Oncogene. 2001, 20 (13): 1547-1555. 10.1038/sj.onc.1204188CrossRefPubMed Whitehead IP, Zohn IE, Der CJ: Rho GTPase-dependent transformation by G protein-coupled receptors. Oncogene. 2001, 20 (13): 1547-1555. 10.1038/sj.onc.1204188CrossRefPubMed
18.
go back to reference Moolenaar WH: Bioactive lysophospholipids and their G protein-coupled receptors. Exp Cell Res. 1999, 253 (1): 230-238. 10.1006/excr.1999.4702CrossRefPubMed Moolenaar WH: Bioactive lysophospholipids and their G protein-coupled receptors. Exp Cell Res. 1999, 253 (1): 230-238. 10.1006/excr.1999.4702CrossRefPubMed
19.
go back to reference Moolenaar WH: Lysophosphatidic Acid, a Multifunctional Phospholipid Messenger. J Biol Chem. 1995, 270 (22): 12949-12952.CrossRefPubMed Moolenaar WH: Lysophosphatidic Acid, a Multifunctional Phospholipid Messenger. J Biol Chem. 1995, 270 (22): 12949-12952.CrossRefPubMed
20.
go back to reference Kostenis E: Novel clusters of receptors for sphingosine-1-phosphate, sphingosylphosphorylcholine, and (lyso)-phosphatidic acid: new receptors for "old" ligands. J Cell Biochem. 2004, 92 (5): 923-936. 10.1002/jcb.20092CrossRefPubMed Kostenis E: Novel clusters of receptors for sphingosine-1-phosphate, sphingosylphosphorylcholine, and (lyso)-phosphatidic acid: new receptors for "old" ligands. J Cell Biochem. 2004, 92 (5): 923-936. 10.1002/jcb.20092CrossRefPubMed
21.
go back to reference Spiegel S, Milstien S: Sphingosine-1-phosphate: an enigmatic signalling lipid. Nat Rev Mol Cell Biol. 2003, 4 (5): 397-407. 10.1038/nrm1103CrossRefPubMed Spiegel S, Milstien S: Sphingosine-1-phosphate: an enigmatic signalling lipid. Nat Rev Mol Cell Biol. 2003, 4 (5): 397-407. 10.1038/nrm1103CrossRefPubMed
22.
go back to reference Umezu-Goto M, Kishi Y, Taira A, Hama K, Dohmae N, Takio K, Yamori T, Mills GB, Inoue K, Aoki J, Arai H: Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production. J Cell Biol. 2002, 158 (2): 227-233. 10.1083/jcb.200204026PubMedCentralCrossRefPubMed Umezu-Goto M, Kishi Y, Taira A, Hama K, Dohmae N, Takio K, Yamori T, Mills GB, Inoue K, Aoki J, Arai H: Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production. J Cell Biol. 2002, 158 (2): 227-233. 10.1083/jcb.200204026PubMedCentralCrossRefPubMed
23.
go back to reference Mills GB, Eder A, Fang X, Hasegawa Y, Mao M, Lu Y, Tanyi J, Tabassam FH, Wiener J, Lapushin R, Yu S, Parrott JA, Compton T, Tribley W, Fishman D, Stack MS, Gaudette D, Jaffe R, Furui T, Aoki J, Erickson JR: Critical role of lysophospholipids in the pathophysiology, diagnosis, and management of ovarian cancer. Cancer Treat Res. 2002, 107: 259-283.PubMed Mills GB, Eder A, Fang X, Hasegawa Y, Mao M, Lu Y, Tanyi J, Tabassam FH, Wiener J, Lapushin R, Yu S, Parrott JA, Compton T, Tribley W, Fishman D, Stack MS, Gaudette D, Jaffe R, Furui T, Aoki J, Erickson JR: Critical role of lysophospholipids in the pathophysiology, diagnosis, and management of ovarian cancer. Cancer Treat Res. 2002, 107: 259-283.PubMed
24.
go back to reference Fishman DA, Liu Y, Ellerbroek SM, Stack MS: Lysophosphatidic acid promotes matrix metalloproteinase (MMP) activation and MMP-dependent invasion in ovarian cancer cells. Cancer Res. 2001, 61 (7): 3194-3199.PubMed Fishman DA, Liu Y, Ellerbroek SM, Stack MS: Lysophosphatidic acid promotes matrix metalloproteinase (MMP) activation and MMP-dependent invasion in ovarian cancer cells. Cancer Res. 2001, 61 (7): 3194-3199.PubMed
25.
go back to reference Mills GB, Moolenaar WH: The emerging role of lysophosphatidic acid in cancer. Nat Rev Cancer. 2003, 3 (8): 582-591. 10.1038/nrc1143CrossRefPubMed Mills GB, Moolenaar WH: The emerging role of lysophosphatidic acid in cancer. Nat Rev Cancer. 2003, 3 (8): 582-591. 10.1038/nrc1143CrossRefPubMed
26.
go back to reference Milstien S, Spiegel S: Targeting sphingosine-1-phosphate: a novel avenue for cancer therapeutics. Cancer Cell. 2006, 9 (3): 148-150. 10.1016/j.ccr.2006.02.025CrossRefPubMed Milstien S, Spiegel S: Targeting sphingosine-1-phosphate: a novel avenue for cancer therapeutics. Cancer Cell. 2006, 9 (3): 148-150. 10.1016/j.ccr.2006.02.025CrossRefPubMed
27.
go back to reference Moolenaar WH, van Meeteren LA, Giepmans BN: The ins and outs of lysophosphatidic acid signaling. Bioessays. 2004, 26 (8): 870-881. 10.1002/bies.20081CrossRefPubMed Moolenaar WH, van Meeteren LA, Giepmans BN: The ins and outs of lysophosphatidic acid signaling. Bioessays. 2004, 26 (8): 870-881. 10.1002/bies.20081CrossRefPubMed
28.
go back to reference Bayless KJ, Davis GE: Sphingosine 1-phosphate markedly induces matrix metalloproteinase and integrin-dependent human endothelial cell invasion and lumen formation in three-dimensional collagen and fibrin matrices. Biochem Biophys Res Commun. 2003, 312 (4): 903-913. 10.1016/j.bbrc.2003.11.017CrossRefPubMed Bayless KJ, Davis GE: Sphingosine 1-phosphate markedly induces matrix metalloproteinase and integrin-dependent human endothelial cell invasion and lumen formation in three-dimensional collagen and fibrin matrices. Biochem Biophys Res Commun. 2003, 312 (4): 903-913. 10.1016/j.bbrc.2003.11.017CrossRefPubMed
29.
go back to reference Langlois S, Gingras D, Beliveau R: Membrane type 1-matrix metalloproteinase (MT1-MMP) cooperates with sphingosine 1-phosphate to induce endothelial cell migration and morphogenic differentiation. Blood. 2004, 103 (8): 3020-3028. 10.1182/blood-2003-08-2968CrossRefPubMed Langlois S, Gingras D, Beliveau R: Membrane type 1-matrix metalloproteinase (MT1-MMP) cooperates with sphingosine 1-phosphate to induce endothelial cell migration and morphogenic differentiation. Blood. 2004, 103 (8): 3020-3028. 10.1182/blood-2003-08-2968CrossRefPubMed
30.
go back to reference Stetler-Stevenson WG, Yu AE: Proteases in invasion: matrix metalloproteinases. Semin Cancer Biol. 2001, 11 (2): 143-152. 10.1006/scbi.2000.0365CrossRefPubMed Stetler-Stevenson WG, Yu AE: Proteases in invasion: matrix metalloproteinases. Semin Cancer Biol. 2001, 11 (2): 143-152. 10.1006/scbi.2000.0365CrossRefPubMed
31.
go back to reference Egeblad M, Werb Z: New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer. 2002, 2 (3): 161-174. 10.1038/nrc745CrossRefPubMed Egeblad M, Werb Z: New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer. 2002, 2 (3): 161-174. 10.1038/nrc745CrossRefPubMed
32.
go back to reference Foda HD, Zucker S: Matrix metalloproteinases in cancer invasion, metastasis and angiogenesis. Drug Discov Today. 2001, 6 (9): 478-482. 10.1016/S1359-6446(01)01752-4CrossRefPubMed Foda HD, Zucker S: Matrix metalloproteinases in cancer invasion, metastasis and angiogenesis. Drug Discov Today. 2001, 6 (9): 478-482. 10.1016/S1359-6446(01)01752-4CrossRefPubMed
33.
34.
go back to reference Vihinen P, Ala-aho R, Kahari VM: Matrix metalloproteinases as therapeutic targets in cancer. Curr Cancer Drug Targets. 2005, 5 (3): 203-220. 10.2174/1568009053765799CrossRefPubMed Vihinen P, Ala-aho R, Kahari VM: Matrix metalloproteinases as therapeutic targets in cancer. Curr Cancer Drug Targets. 2005, 5 (3): 203-220. 10.2174/1568009053765799CrossRefPubMed
35.
go back to reference Coussens LM, Fingleton B, Matrisian LM: Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science. 2002, 295 (5564): 2387-2392. 10.1126/science.1067100CrossRefPubMed Coussens LM, Fingleton B, Matrisian LM: Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science. 2002, 295 (5564): 2387-2392. 10.1126/science.1067100CrossRefPubMed
36.
go back to reference Ohuchi E, Imai K, Fujii Y, Sato H, Seiki M, Okada Y: Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules. J Biol Chem. 1997, 272 (4): 2446-2451. 10.1074/jbc.272.4.2446CrossRefPubMed Ohuchi E, Imai K, Fujii Y, Sato H, Seiki M, Okada Y: Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules. J Biol Chem. 1997, 272 (4): 2446-2451. 10.1074/jbc.272.4.2446CrossRefPubMed
37.
go back to reference Hotary K, Allen E, Punturieri A, Yana I, Weiss SJ: Regulation of cell invasion and morphogenesis in a three-dimensional type I collagen matrix by membrane-type matrix metalloproteinases 1, 2, and 3. J Cell Biol. 2000, 149 (6): 1309-1323. 10.1083/jcb.149.6.1309PubMedCentralCrossRefPubMed Hotary K, Allen E, Punturieri A, Yana I, Weiss SJ: Regulation of cell invasion and morphogenesis in a three-dimensional type I collagen matrix by membrane-type matrix metalloproteinases 1, 2, and 3. J Cell Biol. 2000, 149 (6): 1309-1323. 10.1083/jcb.149.6.1309PubMedCentralCrossRefPubMed
38.
go back to reference Yana I, Seiki M: MT-MMPs play pivotal roles in cancer dissemination. Clin Exp Metastasis. 2002, 19 (3): 209-215. 10.1023/A:1015527220537CrossRefPubMed Yana I, Seiki M: MT-MMPs play pivotal roles in cancer dissemination. Clin Exp Metastasis. 2002, 19 (3): 209-215. 10.1023/A:1015527220537CrossRefPubMed
39.
go back to reference Rozanov DV, Deryugina EI, Ratnikov BI, Monosov EZ, Marchenko GN, Quigley JP, Strongin AY: Mutation analysis of membrane type-1 matrix metalloproteinase (MT1-MMP). The role of the cytoplasmic tail Cys(574), the active site Glu(240), and furin cleavage motifs in oligomerization, processing, and self-proteolysis of MT1-MMP expressed in breast carcinoma cells. J Biol Chem. 2001, 276 (28): 25705-25714. 10.1074/jbc.M007921200CrossRefPubMed Rozanov DV, Deryugina EI, Ratnikov BI, Monosov EZ, Marchenko GN, Quigley JP, Strongin AY: Mutation analysis of membrane type-1 matrix metalloproteinase (MT1-MMP). The role of the cytoplasmic tail Cys(574), the active site Glu(240), and furin cleavage motifs in oligomerization, processing, and self-proteolysis of MT1-MMP expressed in breast carcinoma cells. J Biol Chem. 2001, 276 (28): 25705-25714. 10.1074/jbc.M007921200CrossRefPubMed
40.
go back to reference Davis GE, Senger DR: Endothelial extracellular matrix: biosynthesis, remodeling, and functions during vascular morphogenesis and neovessel stabilization. Circ Res. 2005, 97 (11): 1093-1107. 10.1161/01.RES.0000191547.64391.e3CrossRefPubMed Davis GE, Senger DR: Endothelial extracellular matrix: biosynthesis, remodeling, and functions during vascular morphogenesis and neovessel stabilization. Circ Res. 2005, 97 (11): 1093-1107. 10.1161/01.RES.0000191547.64391.e3CrossRefPubMed
41.
go back to reference Peterson H, Reeves B, Brown R, Hall A, Furth M, Bos J, Jones P, Marshall C: Activated N-ras Controls the Transformed Phenotype of HT1080 Human Fibrosarcoma Cells. Cell. 1987, 51: 803-812. 10.1016/0092-8674(87)90103-6CrossRef Peterson H, Reeves B, Brown R, Hall A, Furth M, Bos J, Jones P, Marshall C: Activated N-ras Controls the Transformed Phenotype of HT1080 Human Fibrosarcoma Cells. Cell. 1987, 51: 803-812. 10.1016/0092-8674(87)90103-6CrossRef
42.
go back to reference Rasheed S, Nelson Rees WA, Toth EM, Arnstein P, Gardner MB: Characterisation of a newly derived human sarcoma cell line (HT1080). Cancer. 1974, 33 (4): 1027-1033. 10.1002/1097-0142(197404)33:4<1027::AID-CNCR2820330419>3.0.CO;2-ZCrossRefPubMed Rasheed S, Nelson Rees WA, Toth EM, Arnstein P, Gardner MB: Characterisation of a newly derived human sarcoma cell line (HT1080). Cancer. 1974, 33 (4): 1027-1033. 10.1002/1097-0142(197404)33:4<1027::AID-CNCR2820330419>3.0.CO;2-ZCrossRefPubMed
43.
go back to reference Siehler S, Manning DR: Pathways of transduction engaged by sphingosine 1-phosphate through G protein-coupled receptors. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 2002, 1582 (1-3): 94-99. 10.1016/S1388-1981(02)00142-7.CrossRef Siehler S, Manning DR: Pathways of transduction engaged by sphingosine 1-phosphate through G protein-coupled receptors. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 2002, 1582 (1-3): 94-99. 10.1016/S1388-1981(02)00142-7.CrossRef
44.
go back to reference Ye X, Ishii I, Kingsbury MA, Chun J: Lysophosphatidic acid as a novel cell survival/apoptotic factor. Biochim Biophys Acta. 2002, 1585 (2-3): 108-113.CrossRefPubMed Ye X, Ishii I, Kingsbury MA, Chun J: Lysophosphatidic acid as a novel cell survival/apoptotic factor. Biochim Biophys Acta. 2002, 1585 (2-3): 108-113.CrossRefPubMed
45.
go back to reference Price LS, Collard JG: Regulation of the cytoskeleton by Rho-family GTPases: implications for tumour cell invasion. Semin Cancer Biol. 2001, 11 (2): 167-173. 10.1006/scbi.2000.0367CrossRefPubMed Price LS, Collard JG: Regulation of the cytoskeleton by Rho-family GTPases: implications for tumour cell invasion. Semin Cancer Biol. 2001, 11 (2): 167-173. 10.1006/scbi.2000.0367CrossRefPubMed
46.
go back to reference Schmitz AA, Govek EE, Bottner B, Van Aelst L: Rho GTPases: signaling, migration, and invasion. Exp Cell Res. 2000, 261 (1): 1-12. 10.1006/excr.2000.5049CrossRefPubMed Schmitz AA, Govek EE, Bottner B, Van Aelst L: Rho GTPases: signaling, migration, and invasion. Exp Cell Res. 2000, 261 (1): 1-12. 10.1006/excr.2000.5049CrossRefPubMed
47.
go back to reference Okamoto H, Takuwa N, Yokomizo T, Sugimoto N, Sakurada S, Shigematsu H, Takuwa Y: Inhibitory regulation of Rac activation, membrane ruffling, and cell migration by the G protein-coupled sphingosine-1-phosphate receptor EDG5 but not EDG1 or EDG3. Mol Cell Biol. 2000, 20 (24): 9247-9261. 10.1128/MCB.20.24.9247-9261.2000PubMedCentralCrossRefPubMed Okamoto H, Takuwa N, Yokomizo T, Sugimoto N, Sakurada S, Shigematsu H, Takuwa Y: Inhibitory regulation of Rac activation, membrane ruffling, and cell migration by the G protein-coupled sphingosine-1-phosphate receptor EDG5 but not EDG1 or EDG3. Mol Cell Biol. 2000, 20 (24): 9247-9261. 10.1128/MCB.20.24.9247-9261.2000PubMedCentralCrossRefPubMed
48.
go back to reference Radeff-Huang J, Seasholtz TM, Matteo RG, Brown JH: G protein mediated signaling pathways in lysophospholipid induced cell proliferation and survival. J Cell Biochem. 2004, 92 (5): 949-966. 10.1002/jcb.20094CrossRefPubMed Radeff-Huang J, Seasholtz TM, Matteo RG, Brown JH: G protein mediated signaling pathways in lysophospholipid induced cell proliferation and survival. J Cell Biochem. 2004, 92 (5): 949-966. 10.1002/jcb.20094CrossRefPubMed
49.
go back to reference Wolf K, Mazo I, Leung H, Engelke K, von Andrian UH, Deryugina EI, Strongin AY, Brocker EB, Friedl P: Compensation mechanism in tumor cell migration: mesenchymal-amoeboid transition after blocking of pericellular proteolysis. J Cell Biol. 2003, 160 (2): 267-277. 10.1083/jcb.200209006PubMedCentralCrossRefPubMed Wolf K, Mazo I, Leung H, Engelke K, von Andrian UH, Deryugina EI, Strongin AY, Brocker EB, Friedl P: Compensation mechanism in tumor cell migration: mesenchymal-amoeboid transition after blocking of pericellular proteolysis. J Cell Biol. 2003, 160 (2): 267-277. 10.1083/jcb.200209006PubMedCentralCrossRefPubMed
50.
go back to reference Nabeshima K, Inoue T, Shimao Y, Sameshima T: Matrix metalloproteinases in tumor invasion: role for cell migration. Pathol Int. 2002, 52 (4): 255-264. 10.1046/j.1440-1827.2002.01343.xCrossRefPubMed Nabeshima K, Inoue T, Shimao Y, Sameshima T: Matrix metalloproteinases in tumor invasion: role for cell migration. Pathol Int. 2002, 52 (4): 255-264. 10.1046/j.1440-1827.2002.01343.xCrossRefPubMed
51.
go back to reference Seiki M, Mori H, Kajita M, Uekita T, Itoh Y: Membrane-type 1 matrix metalloproteinase and cell migration. Biochem Soc Symp. 2003, 253-262. Seiki M, Mori H, Kajita M, Uekita T, Itoh Y: Membrane-type 1 matrix metalloproteinase and cell migration. Biochem Soc Symp. 2003, 253-262.
52.
go back to reference Visse R, Nagase H: Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res. 2003, 92 (8): 827-839. 10.1161/01.RES.0000070112.80711.3DCrossRefPubMed Visse R, Nagase H: Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res. 2003, 92 (8): 827-839. 10.1161/01.RES.0000070112.80711.3DCrossRefPubMed
53.
go back to reference Lambert E, Dasse E, Haye B, Petitfrere E: TIMPs as multifacial proteins. Crit Rev Oncol Hematol. 2004, 49 (3): 187-198.CrossRefPubMed Lambert E, Dasse E, Haye B, Petitfrere E: TIMPs as multifacial proteins. Crit Rev Oncol Hematol. 2004, 49 (3): 187-198.CrossRefPubMed
54.
go back to reference Hotary KB, Allen ED, Brooks PC, Datta NS, Long MW, Weiss SJ: Membrane type I matrix metalloproteinase usurps tumor growth control imposed by the three-dimensional extracellular matrix. Cell. 2003, 114 (1): 33-45. 10.1016/S0092-8674(03)00513-0CrossRefPubMed Hotary KB, Allen ED, Brooks PC, Datta NS, Long MW, Weiss SJ: Membrane type I matrix metalloproteinase usurps tumor growth control imposed by the three-dimensional extracellular matrix. Cell. 2003, 114 (1): 33-45. 10.1016/S0092-8674(03)00513-0CrossRefPubMed
55.
go back to reference Cukierman E, Pankov R, Yamada KM: Cell interactions with three-dimensional matrices. Current Opinion in Cell Biology. 2002, 14 (5): 633-640. 10.1016/S0955-0674(02)00364-2CrossRefPubMed Cukierman E, Pankov R, Yamada KM: Cell interactions with three-dimensional matrices. Current Opinion in Cell Biology. 2002, 14 (5): 633-640. 10.1016/S0955-0674(02)00364-2CrossRefPubMed
56.
go back to reference Xu Y, Shen Z, Wiper DW, Wu M, Morton RE, Elson P, Kennedy AW, Belinson J, Markman M, Casey G: Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers. JAMA. 1998, 280 (8): 719-723. 10.1001/jama.280.8.719CrossRefPubMed Xu Y, Shen Z, Wiper DW, Wu M, Morton RE, Elson P, Kennedy AW, Belinson J, Markman M, Casey G: Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers. JAMA. 1998, 280 (8): 719-723. 10.1001/jama.280.8.719CrossRefPubMed
57.
go back to reference Clair T, Aoki J, Koh E, Bandle RW, Nam SW, Ptaszynska MM, Mills GB, Schiffmann E, Liotta LA, Stracke ML: Autotaxin hydrolyzes sphingosylphosphorylcholine to produce the regulator of migration, sphingosine-1-phosphate. Cancer Res. 2003, 63 (17): 5446-5453.PubMed Clair T, Aoki J, Koh E, Bandle RW, Nam SW, Ptaszynska MM, Mills GB, Schiffmann E, Liotta LA, Stracke ML: Autotaxin hydrolyzes sphingosylphosphorylcholine to produce the regulator of migration, sphingosine-1-phosphate. Cancer Res. 2003, 63 (17): 5446-5453.PubMed
58.
go back to reference Tokumura A, Majima E, Kariya Y, Tominaga K, Kogure K, Yasuda K, Fukuzawa K: Identification of human plasma lysophospholipase D, a lysophosphatidic acid-producing enzyme, as autotaxin, a multifunctional phosphodiesterase. J Biol Chem. 2002, 277 (42): 39436-39442. 10.1074/jbc.M205623200CrossRefPubMed Tokumura A, Majima E, Kariya Y, Tominaga K, Kogure K, Yasuda K, Fukuzawa K: Identification of human plasma lysophospholipase D, a lysophosphatidic acid-producing enzyme, as autotaxin, a multifunctional phosphodiesterase. J Biol Chem. 2002, 277 (42): 39436-39442. 10.1074/jbc.M205623200CrossRefPubMed
59.
go back to reference Yamada T, Sato K, Komachi M, Malchinkhuu E, Tobo M, Kimura T, Kuwabara A, Yanagita Y, Ikeya T, Tanahashi Y, Ogawa T, Ohwada S, Morishita Y, Ohta H, Im DS, Tamoto K, Tomura H, Okajima F: Lysophosphatidic acid (LPA) in malignant ascites stimulates motility of human pancreatic cancer cells through LPA1. J Biol Chem. 2004, 279 (8): 6595-6605. 10.1074/jbc.M308133200CrossRefPubMed Yamada T, Sato K, Komachi M, Malchinkhuu E, Tobo M, Kimura T, Kuwabara A, Yanagita Y, Ikeya T, Tanahashi Y, Ogawa T, Ohwada S, Morishita Y, Ohta H, Im DS, Tamoto K, Tomura H, Okajima F: Lysophosphatidic acid (LPA) in malignant ascites stimulates motility of human pancreatic cancer cells through LPA1. J Biol Chem. 2004, 279 (8): 6595-6605. 10.1074/jbc.M308133200CrossRefPubMed
60.
go back to reference Saba JD, Hla T: Point-counterpoint of sphingosine 1-phosphate metabolism. Circ Res. 2004, 94 (6): 724-734. 10.1161/01.RES.0000122383.60368.24CrossRefPubMed Saba JD, Hla T: Point-counterpoint of sphingosine 1-phosphate metabolism. Circ Res. 2004, 94 (6): 724-734. 10.1161/01.RES.0000122383.60368.24CrossRefPubMed
61.
go back to reference van Meeteren LA, Ruurs P, Christodoulou E, Goding JW, Takakusa H, Kikuchi K, Perrakis A, Nagano T, Moolenaar WH: Inhibition of autotaxin by lysophosphatidic acid and sphingosine 1-phosphate. J Biol Chem. 2005, 280 (22): 21155-21161. 10.1074/jbc.M413183200CrossRefPubMed van Meeteren LA, Ruurs P, Christodoulou E, Goding JW, Takakusa H, Kikuchi K, Perrakis A, Nagano T, Moolenaar WH: Inhibition of autotaxin by lysophosphatidic acid and sphingosine 1-phosphate. J Biol Chem. 2005, 280 (22): 21155-21161. 10.1074/jbc.M413183200CrossRefPubMed
62.
go back to reference Stadler CR, Knyazev P, Bange J, Ullrich A: FGFR4 GLY388 isotype suppresses motility of MDA-MB-231 breast cancer cells by EDG-2 gene repression. Cell Signal. 2006, 18 (6): 783-794. 10.1016/j.cellsig.2005.07.002CrossRefPubMed Stadler CR, Knyazev P, Bange J, Ullrich A: FGFR4 GLY388 isotype suppresses motility of MDA-MB-231 breast cancer cells by EDG-2 gene repression. Cell Signal. 2006, 18 (6): 783-794. 10.1016/j.cellsig.2005.07.002CrossRefPubMed
63.
go back to reference Deryugina EI, Zijlstra A, Partridge JJ, Kupriyanova TA, Madsen MA, Papagiannakopoulos T, Quigley JP: Unexpected effect of matrix metalloproteinase down-regulation on vascular intravasation and metastasis of human fibrosarcoma cells selected in vivo for high rates of dissemination. Cancer Res. 2005, 65 (23): 10959-10969. 10.1158/0008-5472.CAN-05-2228CrossRefPubMed Deryugina EI, Zijlstra A, Partridge JJ, Kupriyanova TA, Madsen MA, Papagiannakopoulos T, Quigley JP: Unexpected effect of matrix metalloproteinase down-regulation on vascular intravasation and metastasis of human fibrosarcoma cells selected in vivo for high rates of dissemination. Cancer Res. 2005, 65 (23): 10959-10969. 10.1158/0008-5472.CAN-05-2228CrossRefPubMed
64.
go back to reference Visentin B, Vekich JA, Sibbald BJ, Cavalli AL, Moreno KM, Matteo RG, Garland WA, Lu Y, Yu S, Hall HS, Kundra V, Mills GB, Sabbadini RA: Validation of an anti-sphingosine-1-phosphate antibody as a potential therapeutic in reducing growth, invasion, and angiogenesis in multiple tumor lineages. Cancer Cell. 2006, 9 (3): 225-238. 10.1016/j.ccr.2006.02.023CrossRefPubMed Visentin B, Vekich JA, Sibbald BJ, Cavalli AL, Moreno KM, Matteo RG, Garland WA, Lu Y, Yu S, Hall HS, Kundra V, Mills GB, Sabbadini RA: Validation of an anti-sphingosine-1-phosphate antibody as a potential therapeutic in reducing growth, invasion, and angiogenesis in multiple tumor lineages. Cancer Cell. 2006, 9 (3): 225-238. 10.1016/j.ccr.2006.02.023CrossRefPubMed
65.
go back to reference Coussens LM, Tinkle CL, Hanahan D, Werb Z: MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell. 2000, 103 (3): 481-490. 10.1016/S0092-8674(00)00139-2PubMedCentralCrossRefPubMed Coussens LM, Tinkle CL, Hanahan D, Werb Z: MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell. 2000, 103 (3): 481-490. 10.1016/S0092-8674(00)00139-2PubMedCentralCrossRefPubMed
66.
go back to reference Schnaeker EM, Ossig R, Ludwig T, Dreier R, Oberleithner H, Wilhelmi M, Schneider SW: Microtubule-dependent matrix metalloproteinase-2/matrix metalloproteinase-9 exocytosis: prerequisite in human melanoma cell invasion. Cancer Res. 2004, 64 (24): 8924-8931. 10.1158/0008-5472.CAN-04-0324CrossRefPubMed Schnaeker EM, Ossig R, Ludwig T, Dreier R, Oberleithner H, Wilhelmi M, Schneider SW: Microtubule-dependent matrix metalloproteinase-2/matrix metalloproteinase-9 exocytosis: prerequisite in human melanoma cell invasion. Cancer Res. 2004, 64 (24): 8924-8931. 10.1158/0008-5472.CAN-04-0324CrossRefPubMed
67.
go back to reference Wu WT, Chen CN, Lin CI, Chen JH, Lee H: Lysophospholipids enhance matrix metalloproteinase-2 expression in human endothelial cells. Endocrinology. 2005, 146 (8): 3387-3400. 10.1210/en.2004-1654CrossRefPubMed Wu WT, Chen CN, Lin CI, Chen JH, Lee H: Lysophospholipids enhance matrix metalloproteinase-2 expression in human endothelial cells. Endocrinology. 2005, 146 (8): 3387-3400. 10.1210/en.2004-1654CrossRefPubMed
68.
go back to reference Bornstein MB: Reconstituted rat-tail collagen used as a substrate for tissue cultures on coverslips in Maximov slides and rollertubes. Lab Invest. 1958, 7: 134-137.PubMed Bornstein MB: Reconstituted rat-tail collagen used as a substrate for tissue cultures on coverslips in Maximov slides and rollertubes. Lab Invest. 1958, 7: 134-137.PubMed
69.
go back to reference Bayless KJ, Davis GE: The Cdc42 and Rac1 GTPases are required for capillary lumen formation in three-dimensional extracellular matrices. J Cell Sci. 2002, 115 (6): 1123-1136.PubMed Bayless KJ, Davis GE: The Cdc42 and Rac1 GTPases are required for capillary lumen formation in three-dimensional extracellular matrices. J Cell Sci. 2002, 115 (6): 1123-1136.PubMed
70.
go back to reference Salazar R, Bell SE, Davis GE: Coordinate induction of the actin cytoskeletal regulatory proteins gelsolin, vasodilator-stimulated phosphoprotein, and profilin during capillary morphogenesis in vitro. Exp Cell Res. 1999, 249 (1): 22-32. 10.1006/excr.1999.4460CrossRefPubMed Salazar R, Bell SE, Davis GE: Coordinate induction of the actin cytoskeletal regulatory proteins gelsolin, vasodilator-stimulated phosphoprotein, and profilin during capillary morphogenesis in vitro. Exp Cell Res. 1999, 249 (1): 22-32. 10.1006/excr.1999.4460CrossRefPubMed
71.
go back to reference Davis GE, Camarillo CW: An alpha 2 beta 1 integrin-dependent pinocytic mechanism involving intracellular vacuole formation and coalescence regulates capillary lumen and tube formation in three-dimensional collagen matrix. Exp Cell Res. 1996, 224 (1): 39-51. 10.1006/excr.1996.0109CrossRefPubMed Davis GE, Camarillo CW: An alpha 2 beta 1 integrin-dependent pinocytic mechanism involving intracellular vacuole formation and coalescence regulates capillary lumen and tube formation in three-dimensional collagen matrix. Exp Cell Res. 1996, 224 (1): 39-51. 10.1006/excr.1996.0109CrossRefPubMed
72.
go back to reference Saunders WB, Bayless KJ, Davis GE: MMP-1 activation by serine proteases and MMP-10 induces human capillary tubular network collapse and regression in 3D collagen matrices. J Cell Sci. 2005, 118 (Pt 10): 2325-2340. 10.1242/jcs.02360CrossRefPubMed Saunders WB, Bayless KJ, Davis GE: MMP-1 activation by serine proteases and MMP-10 induces human capillary tubular network collapse and regression in 3D collagen matrices. J Cell Sci. 2005, 118 (Pt 10): 2325-2340. 10.1242/jcs.02360CrossRefPubMed
73.
go back to reference He TC, Zhou S, da Costa LT, Yu J, Kinzler KW, Vogelstein B: A simplified system for generating recombinant adenoviruses. PNAS. 1998, 95 (5): 2509-2514. 10.1073/pnas.95.5.2509PubMedCentralCrossRefPubMed He TC, Zhou S, da Costa LT, Yu J, Kinzler KW, Vogelstein B: A simplified system for generating recombinant adenoviruses. PNAS. 1998, 95 (5): 2509-2514. 10.1073/pnas.95.5.2509PubMedCentralCrossRefPubMed
Metadata
Title
Tumor cell invasion of collagen matrices requires coordinate lipid agonist-induced G-protein and membrane-type matrix metalloproteinase-1-dependent signaling
Authors
Kevin E Fisher
Andreia Pop
Wonshill Koh
Nicholas J Anthis
W Brian Saunders
George E Davis
Publication date
01-12-2006
Publisher
BioMed Central
Published in
Molecular Cancer / Issue 1/2006
Electronic ISSN: 1476-4598
DOI
https://doi.org/10.1186/1476-4598-5-69

Other articles of this Issue 1/2006

Molecular Cancer 1/2006 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine